Original Research
Published on 27 Jan 2023
Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1014150
- 8,504 views
- 6 citations
